Long-lasting improvement of myocardial perfusion and chronic refractory angina after autologous intramyocardial PBSC transplantation
- 1 January 2005
- journal article
- case report
- Published by Elsevier in Cytotherapy
- Vol. 7 (6) , 494-496
- https://doi.org/10.1080/14653240500361392
Abstract
We report the case of a 60-year-old man with patent coronary by-pass grafts on the left anterior descending and circumflex coronary arteries, who experienced recurrent Canadian class IV angina refractory to medical and interventional treatments for a dominant right coronary artery occlusion. He underwent autologous PBSC transplant into the inferior ventricular wall through a minimally invasive approach as a stand-alone therapy, in an attempt to induce therapeutic angiogenesis. Six months after the operation, angina significantly ameliorated; scintigraphy and coronary angiography showed a marked improvement in perfusion of the target injection area. These benefits had persisted at 25 months after stem cell transplant.Keywords
This publication has 6 references indexed in Scilit:
- Role of Inflammatory Mediators in AngiogenesisCurrent Drug Targets - Inflammation & Allergy, 2005
- Autologous Peripheral Blood Stem Cell Transplantation for Myocardial Regeneration: A Novel Strategy for Cell Collection and Surgical InjectionThe Annals of Thoracic Surgery, 2004
- Bone Marrow–Derived Cells for Enhancing Collateral DevelopmentCirculation Research, 2004
- Endothelial Progenitor CellsCirculation Research, 2004
- The human coronary collateral circulationHeart, 2003
- Origin of endothelial progenitors in human postnatal bone marrowJournal of Clinical Investigation, 2002